Upgrade Now

RUA Life Sciences sees US orders improve

By Iain Gilbert

Date: Tuesday 11 Aug 2020

RUA Life Sciences sees US orders improve

(Sharecast News) - Medical device business RUA Life Sciences said on Tuesday that orders had increased over the last eight weeks as elective surgeries in the US seemed to have made a faster recovery than in Europe.
RUA said the increase in operating theatre activity had brought about "a similar impact" on orders from its largest customer, which has now placed orders in five out of the last eight weeks with weekly order values being at higher rates than the pre-Covid averages.

The AIM-listed group now expects shipments based on current orders received to average around 90% of pre-pandemic levels over the next quarter.

In order to meet customer delivery schedules, RUA highlighted that furloughed staff had now returned to work on at least a part-time basis, with full manufacturing activity forecast to resume "shortly".

As of 0935 BST, RUA shares were up 3.21% at 96.50p.


Email this article to a friend

or share it with one of these popular networks:

Top of Page